Secure Life Science (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 28-06-2024
- Paid Up Capital ₹ 1.00 M
as on 28-06-2024
- Company Age 15 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.10 M
as on 28-06-2024
- Revenue -28.63%
(FY 2021)
- Profit -30.52%
(FY 2021)
- Ebitda -25.89%
(FY 2021)
- Net Worth 7.46%
(FY 2021)
- Total Assets 13.91%
(FY 2021)
About Secure Life Science (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹7.10 M.
Rajlaxmi Patro, Rasmita Mahapatra, and Ashok Panigrahy serve as directors at the Company.
- CIN/LLPIN
U51397OR2009PTC010594
- Company No.
010594
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Feb 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Ganjam, Odisha, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Secure Life Science (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Panigrahy  | Managing Director | 03-Feb-2009 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajlaxmi Patro | Director | 03-Feb-2009 | Current |
| Rasmita Mahapatra | Director | 03-Feb-2009 | Current |
Financial Performance of Secure Life Science (India).
Secure Life Science (India) Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 28.63% decrease. The company also saw a substantial fall in profitability, with a 30.52% decrease in profit. The company's net worth moved up by a moderate rise of 7.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Secure Life Science (India)?
In 2021, Secure Life Science (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Nkethical Laboratories (Opc) Private LimitedActive 2 years 5 months
Ashok Panigrahy is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 12 Mar 2013 | ₹7.10 M | Open |
How Many Employees Work at Secure Life Science (India)?
Unlock and access historical data on people associated with Secure Life Science (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Secure Life Science (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Secure Life Science (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
